Haruka Hattori1, Masayuki Maeda2, Yasuhiro Nagatomo3, Takahiro Takuma3, Yoshihito Niki3, Yuika Naito4, Tadanori Sasaki4, Keiko Ishino5. 1. Division of Infection Control Sciences, Department of Clinical Pharmacy, School of Pharmacy, Showa University, Tokyo, Japan; Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan. 2. Division of Infection Control Sciences, Department of Clinical Pharmacy, School of Pharmacy, Showa University, Tokyo, Japan. Electronic address: m-maeda@pharm.showa-u.ac.jp. 3. Division of Clinical Infectious Diseases, Department of Medicine, School of Medicine, Showa University, Tokyo, Japan. 4. Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan. 5. Division of Infection Control Sciences, Department of Clinical Pharmacy, School of Pharmacy, Showa University, Tokyo, Japan.
Abstract
BACKGROUND: Few published data are available on the morbidity and mortality of bloodstream infections (BSIs) in Japan. We sought to investigate the epidemiology of BSIs, the involvement of antimicrobial resistance, and the factors that influence patient prognosis. METHODS: This single-center study retrospectively evaluated patients who were found to have positive blood cultures at a tertiary teaching hospital between January 2012 and December 2016. RESULTS: A total of 2,105 patients with BSIs were included; 1,786 survived and 319 died, and the 30-day mortality rate was 15.2% over the 5-year study period. BSIs caused by yeasts were independently associated with 30-day mortality. The 30-day mortality rate of BSIs caused by extended-spectrum beta lactamase-producing gram-negative bacteria was significantly higher than that of BSIs caused by nonproducing bacteria. DISCUSSION: The differences in mortality may be caused by differences in the distribution of pathogens and in the delivery of health care. CONCLUSIONS: This study reported epidemiology and antimicrobial resistance data of BSIs in Japan and identified several risk factors associated with 30-day mortality. National surveillance of BSIs is required in Japan for comparison with other countries.
BACKGROUND: Few published data are available on the morbidity and mortality of bloodstream infections (BSIs) in Japan. We sought to investigate the epidemiology of BSIs, the involvement of antimicrobial resistance, and the factors that influence patient prognosis. METHODS: This single-center study retrospectively evaluated patients who were found to have positive blood cultures at a tertiary teaching hospital between January 2012 and December 2016. RESULTS: A total of 2,105 patients with BSIs were included; 1,786 survived and 319 died, and the 30-day mortality rate was 15.2% over the 5-year study period. BSIs caused by yeasts were independently associated with 30-day mortality. The 30-day mortality rate of BSIs caused by extended-spectrum beta lactamase-producing gram-negative bacteria was significantly higher than that of BSIs caused by nonproducing bacteria. DISCUSSION: The differences in mortality may be caused by differences in the distribution of pathogens and in the delivery of health care. CONCLUSIONS: This study reported epidemiology and antimicrobial resistance data of BSIs in Japan and identified several risk factors associated with 30-day mortality. National surveillance of BSIs is required in Japan for comparison with other countries.
Authors: Sarah Weber; Aaron Magh; Michael Hogardt; Volkhard A J Kempf; Maria J G T Vehreschild; Hubert Serve; Sebastian Scheich; Björn Steffen Journal: Ann Hematol Date: 2021-05-03 Impact factor: 3.673
Authors: In Young Yoo; Jayho Han; Sung Il Ha; Young Jong Cha; Shin Dong Pil; Yeon-Joon Park Journal: J Clin Lab Anal Date: 2021-05-03 Impact factor: 2.352
Authors: Martin Holmbom; Vidar Möller; Lennart E Nilsson; Christian G Giske; Mamun-Ur Rashid; Mats Fredrikson; Anita Hällgren; Håkan Hanberger; Åse Östholm Balkhed Journal: PLoS One Date: 2020-03-27 Impact factor: 3.240